GH Research(GHRS)
$18.56+0.31 (+1.70%)
GHRS
GH Research financials statements
$18.56
At close:+0.31 (+1.70%)
Want to see GHRS full AI Analyst Report?
GH Research (GHRS) Ratios
408 Followers
GH Research Ratios
GHRS's free cash flow for Q3 2026 was $-10.67M. For the 2026 fiscal year, GHRS's free cash flow was decreased by $-21.00K and operating cash flow was $-10.65M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 34.13 | 17.23 | 24.49 | 37.07 | 101.80 |
| Quick Ratio | 34.13 | 17.23 | 24.49 | 37.09 | 100.70 |
| Cash Ratio | 29.39 | 11.26 | 11.70 | 36.51 | 100.68 |
| Solvency Ratio | -5.62 | -4.15 | -4.81 | -4.93 | -3.34 |
| Operating Cash Flow Ratio | -5.20 | -4.72 | -4.97 | -5.76 | -5.56 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -165.82 | -97.19 | 0.00 | 0.00 |
| Net Current Asset Value | $ 277.45M | $ 144.90M | $ 156.76M | $ 164.00M | $ 277.09M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.03 | 1.05 | 1.03 | 1.02 | 1.01 |
| Debt Service Coverage Ratio | -102.51 | -39.71 | -33.03 | 0.00 | -1019.33 |
| Interest Coverage Ratio | -131.05 | -70.17 | -57.02 | 0.00 | -1677.78 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.02 | 0.03 | 0.03 | 0.00 | 0.00 |
| Net Debt to EBITDA | 5.18 | 2.60 | 2.20 | 7.41 | 30.17 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 79.53% | 77.44% | 86.33% | 73.50% | 60.94% |
| Return on Assets (ROA) | -16.74% | -20.69% | -15.73% | -8.83% | -3.29% |
| Return on Equity (ROE) | -17.25% | -21.77% | -16.25% | -8.99% | -3.32% |
| Return on Capital Employed (ROCE) | -21.68% | -28.06% | -18.77% | -12.23% | -5.45% |
| Return on Invested Capital (ROIC) | -21.65% | -28.02% | -18.74% | -12.23% | -5.45% |
| Return on Tangible Assets | -16.74% | -20.69% | -15.73% | -8.83% | -3.29% |
| Earnings Yield | -6.22% | -10.70% | -11.79% | -4.44% | -0.76% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.09 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -4110.88 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 4110.88 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.71 | -0.81 | -0.64 | -0.50 | -0.29 |
| Free Cash Flow Per Share | -0.72 | -0.81 | -0.64 | -0.50 | -0.30 |
| Dividend Paid and CapEx Coverage Ratio | -359.93 | -862.96 | -333.36 | -391.03 | -146.95 |
| Capital Expenditure Coverage Ratio | -359.93 | -862.96 | -333.36 | -391.03 | -146.95 |
| Operating Cash Flow Coverage Ratio | -85.06 | -67.76 | -34.23 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -5.63% | -11.62% | -11.08% | -5.19% | -1.27% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -16.08 | -9.33 | -8.48 | -22.52 | -131.89 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 2.77 | 2.04 | 1.38 | 2.02 | 4.38 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -17.75 | -8.60 | -9.02 | -19.25 | -78.87 |
| Price-to-Operating Cash Flow Ratio | -17.80 | -8.61 | -9.05 | -19.30 | -79.41 |
| Price-to-Earnings Growth (PEG) Ratio | -3.01 | -0.91 | -0.02 | 1.01 | -0.12 |
| Enterprise Value Multiple | -11.16 | -6.84 | -6.37 | -15.16 | -102.12 |
| Enterprise Value | 529.50M | 264.03M | 224.29M | 339.69M | 936.87M |
| EV to EBITDA | -11.16 | -6.84 | -6.37 | -15.16 | -102.12 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -12.12 | -6.24 | -6.71 | -12.93 | -60.89 |
| EV to Operating Cash Flow | -12.16 | -6.24 | -6.73 | -12.97 | -61.30 |
| Tangible Book Value Per Share | 4.58 | 3.44 | 4.21 | 4.80 | 5.33 |
| Shareholders’ Equity Per Share | 4.58 | 3.44 | 4.21 | 4.80 | 5.33 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.79 | -0.75 | -0.68 | -0.43 | -0.18 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.01 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.90 | 1.09 | 0.94 | 1.17 | 1.66 |
Currency in USD

